Sunday, October 04, 2015
Current Weather
Loading Current Weather....
Published: Friday, 7/11/2008

Local drug firm gains $300,000 investment

A Regional Growth Partnership venture capital fund announced yesterday it will invest $300,000 in a local pharmaceutical company that is to begin clinical trials in Toledo for a drug to treat Alzheimer s and other nervous-system diseases.

The Rocket Ventures investment is with Madison, Wis.-based Mithridion Inc., successor to Cognitive Pharmaceuticals Ltd., a firm set up by University of Toledo Profs. Wayne Hoss and William Messer, Jr.

Mithridion took over Cognitive Pharmaceuticals last month with $2.3 million in financing from a Wisconsin venture capital firm. Dr. Hoss said its drug for Alzheimer s differs from others by treating memory loss, confusion, and other symptoms and also getting at underlying causes of the disease and protecting the brain.

Recommended for You

Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. If a comment violates these standards or our privacy statement or visitor's agreement, click the "X" in the upper right corner of the comment box to report abuse. To post comments, you must be a Facebook member. To find out more, please visit the FAQ.